Veinamin® AM - 100 Tablets - 100 day supply
One of our most popular products! Read below for scientific evidence that supports the use of Veinamin® AM to treat venous insufficiency.
Approximately 25 million Americans suffer from superficial venous reflux disease. Believe it or not, superficial venous reflux disease (venous insufficiency) is not limited to unsightly varicose veins. One can have superficial venous reflux disease alone, superficial venous reflux disease with varicose veins, or varicose veins without venous reflux disease. Venous reflux disease is also known as venous insufficiency.
Venous reflux or venous insufficiency develops when the valves that usually keep blood flowing out of your legs become diseased and don't function as "one-way" valves. The blood 'refluxes' back into the legs. In essence, it is like gastroesophageal reflux disease (GERD) when acid in the stomach goes the wrong way - instead of moving down into the small intestine, it refluxes into the esophagus, causing acid reflux symptoms. Venous reflux is venous blood being pushed back into the legs (venous blood pooling or venous insufficiency), instead of it moving towards the heart and lungs for proper oxygenation.
This pooling of blood and this pressure force generates varicose veins and all of the problems such as discoloration of the skin with bronzing, pigmentation and eventually skin ulceration - called venous stasis ulceration. The likelihood of venous stasis ulceration as a lifetime risk in individuals with venous reflux disease is 1 in 24. That means that 1 in 24 patients with venous insufficiency will develop the ultimate complication of having had untreated venous insufficiency, venous stasis ulceration or lipodermatosclerosis.
Patients with venous insufficiency can wear stockings to help support the failing valves and/or have vein stripping, vein ligation procedures or endovenous ablation procedures such as VenaCure EVLT , VNUS Closure (Venefit Procedure) or the ClariVein Procedure. No matter which treatment option is chosen, compression stockings need to be worn to reduce the symptoms associated with venous insufficiency (aching, pain, swelling, heaviness of the legs) and to reduce the likelihood of developing more vein problems in the future. However, a recent study by the Cochrane Collaboration stated that the objective of their investigational study was based on the premise that "conservative therapy of chronic venous insufficiency (CVI) consists largely of compression treatment.
However, this often causes discomfort and has been associated with poor compliance. Therefore, oral drug treatment is an attractive option". Their research demonstrated that "there was an improvement in chronic venous insufficiency (CVI) related signs and symptoms with horse chestnut extract compared with placebo. According to their analysis of the published literature, "leg pain was assessed in seven placebo-controlled trials. Six of these trials reported a significant reduction of leg pain in the horse chestnut extract groups compared with the placebo groups, while another study reported a statistically significant improvement compared with baseline". The meta analysis of these trials by the Cochrane Collaboration as it relates to venous insufficiency and horse chestnut extract (escin) in effect demonstated that "horse chestnut extract may be as effective as treatment with compression stockings. Adverse events were usually mild and infrequent". The Cochrane Collaboration is a very prestigious research group with a lot of weight being attributed to these types of practice guideline recommendations.
Uberceuticals is not affiliated with the Cochrane Collaboration.
Features and Benefits
Veinamin® AM was specifically designed by two Board Certified Phlebologists (vein specialists certified by the American Board of Venous and Lymphatic Medicine) for men and women who have varicose veins, spider veins and venous reflux disease (chronic venous insufficiency, CVI). This proprietary blend of herbs support 1) the structural integrity of vein walls; 2) they protect the inside lining of veins (venous endothelium) and 3) prevent vein valves from leaking. The bioflavonoid (Gotu Kola) has phlebotonic and anti-inflammatory properties. Horse chestnut extract (aescin or escin) has been shown to be as effective as wearing compression stockings for the treatment of chronic venous insufficiency according to the Cochrane Collaboration, a very prestigious scientific group in medicine.
This morning dose of Veinamin® AM aids in maintaining and promoting venous integrity and venous health.
Veinamin® AM should be taken in conjunction with Veinamin® PM.
Veinamin® AM and Veinamin® PM have been clinically tested at our Vein Treatment Centers and are recommended to all patients who have venous insufficiency and/or varicose veins.
Horse Chestnut Extract (20% Aescin) and Gotu Kola
Uberceuticals® formulas are proprietary, meaning that the herbs and minerals are compounded to our specifications and patented in a manner that cannot be used or duplicated by other companies or third party manufacturers. Other lesser brands may formulate products with similar ingredients, but the ratios of ingredients in our product are clinically tested and cannot be duplicated. Uberceuticals® is the Leader in Vein Care Science.
Take one capsule of Veinamin® AM in the morning, preferably with food. Horse chestnut extract and Gotu Kola can be taken with all medications except for the blood thinner coumadin, trade name Warfarin®. We recommend that you take Veinamin® AM in conjunction with Veinamin® PM for maximal efficacy and proper dosing of the active ingredients of these dietary supplements.
Unless recommended by your doctor, do not take Veinamin products with the blood thinner coumadin (warfarin) or their equivalents (heparin, lovenox, etc).